Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Investing Cash Flow & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · Investing Cash Flow

LCTX Investing Cash Flow

Latest reported-$13.71Mperiod endingJun 30, 2026

LCTX Cash from Investing ($0.00 → -$13.71M)

Annual investing cash flow

High-resolution chart · PNG

LCTX investing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Investing Cash Flow — Annual fiscal periods (USD)
Period ending	Investing Cash Flow (USD)
Dec 31, 2025	-13,457,000
Dec 31, 2024	-2,308,000
Dec 31, 2023	46,449,000
Dec 31, 2022	-46,159,000
Dec 31, 2021	9,745,000
Dec 31, 2020	13,038,000
Dec 31, 2019	16,957,000
Dec 31, 2018	11,816,000
Dec 31, 2017	-10,225,000
Dec 31, 2016	-10,889,000
Dec 31, 2015	-7,441,000
Dec 31, 2014	-1,007,804
Dec 31, 2013	-3,665,587
Dec 31, 2012	-104,687
Dec 31, 2011	-1,202,713
Dec 31, 2010	3,197,419
Dec 31, 2009	-46,226
Dec 31, 2008	-909,872
Dec 31, 2007	-6,473
Dec 31, 2006	-10,664
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	-3,831
Dec 31, 2001	-5,116
Dec 31, 2000	-33,402
Dec 31, 1999	-161,719
Dec 31, 1998	0
Jun 30, 1998	-100,000
Jun 30, 1996	0
Jun 30, 1995	4,900,000
Jun 30, 1994	-3,100,000
Jun 30, 1993	-2,000,000
Jun 30, 1992	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.